Jonathan Lim

Jonathan E.
Lim was the founder of Eclipse Therapeutics, Inc. founded in 2011, serving as Chairman & Chief Executive Officer from 2011 to 2012.
Dr. Lim is the founder of Boundless Bio, Inc. founded in 2018, serving as Chairman since 2018.
Dr. Lim is the founder of City Hill Ventures LLC founded in 2010, serving as Venture Partner since 2010.
Dr. Lim was the founder of Bonti, Inc. founded in 2015, serving as Chairman from 2015 to 2018.
Dr. Lim was the founder of Ignyta, Inc. founded in 2011, serving as Chairman, President & Chief Executive Officer from 2013 to 2018.
Dr. Lim is the founder of Ignyta Operating, Inc. founded in 2011, serving as Chairman, President & Chief Executive Officer since 2013.
Dr. Lim is the founder of Erasca, Inc. founded in 2018, serving as Chairman & Chief Executive Officer since 2019.
Dr. Lim is also the founder of Medenovo Management LLC..
Dr. Lim is currently Independent Director at Maze Therapeutics, Inc. since 2019.
Dr. Lim is currently Member-Interdisciplinary Biosciences Council at Stanford University since 2014.
Dr. Lim is currently Venture Partner at ARCH Venture Partners LLC since 2018.
Dr. Lim is currently Member-Overseers Board at The Scripps Research Institute since 2018.
Dr. Lim is currently Member-Visitors Board at Moores Cancer Center since 2015.
Dr. Lim was President, Chief Executive Officer & Director at Halozyme Therapeutics, Inc. from 2005 to 2010.
Dr. Lim was Independent Non-Executive Director at Bionomics Ltd. from 2013 to 2015.
Dr. Lim was Member-Strategic Planning Committee at American Medical Association from 2002 to 2005.
Dr. Lim completed undergraduate and graduate degrees at Stanford University.
Dr. Lim completed a graduate degree at Harvard University.
Dr. Lim completed a doctorate at McGill University.